LAZARD ASSET MANAGEMENT LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 138 filers reported holding ANI PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$175
+29.6%
3,022
+19.6%
0.00%
Q2 2023$135
+145.5%
2,527
+84.3%
0.00%
Q4 2022$55
-100.0%
1,371
-97.9%
0.00%
-100.0%
Q1 2016$2,190,000
-20.9%
65,073
+6.0%
0.01%
-16.7%
Q4 2015$2,770,00061,3900.01%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 328,494$15,137,0004.72%
TANG CAPITAL MANAGEMENT LLC 300,000$13,824,0002.78%
Mesirow Financial Investment Management, Inc. 12,277$566,0001.63%
Parkman Healthcare Partners LLC 137,226$6,323,0001.40%
Global Alpha Capital Management Ltd. 284,831$13,125,0001.27%
Stonepine Capital Management, LLC 52,290$2,410,0001.11%
1492 Capital Management LLC 43,611$2,010,0000.99%
MARATHON CAPITAL MANAGEMENT 74,770$3,445,0000.81%
Walthausen & Co., LLC 61,456$2,832,0000.74%
Rubric Capital Management LP 307,557$14,172,0000.67%
View complete list of ANI PHARMACEUTICALS INC shareholders